Monthly Archives: March 2010
Turn Everyday Shopping Into Everyday Giving
What would you do if we told you that every time you shopped online you were helping the work of the Ovarian Cancer National Alliance in our effort to advance the interests of women with ovarian cancer? Well, it’s true. … Continue reading
Posted in Blog Leave a comment
Patents On Breast Cancer Genes Ruled Invalid In ACLU/PubPat Case
(ACLU Press Release) MARCH 29, 2010 NEW YORK – Patents on genes associated with hereditary breast and ovarian cancer are invalid, ruled a New York federal court today. The precedent-setting ruling marks the first time a court has found patents … Continue reading
Posted in News Leave a comment
Tamoxifen for relapse of ovarian cancer
BACKGROUND: Tamoxifen is an important drug for treating breast cancer. Ovarian cancer cells are known to possess receptors for hormones and may thus also respond to tamoxifen. OBJECTIVES: Tamoxifen is used to treat breast cancer in women whose tumours have … Continue reading
Posted in Blog, News Tagged outcomes, quality of life, recurrence, Research, science Leave a comment
OU doctor leads treatment study for ovarian cancer
A doctor at the OU Health Sciences Center and OU Cancer Institute is directing a nationwide clinical trial to study treatments for ovarian cancer. Dr. Joan Walker, gynecologic oncologist, is leading the trial for the Gynecological Oncology Group. The trial … Continue reading
Survivors on set at Tristar Products, Inc.
By Jaimie Griffin What a busy week! Georgi and I just got back from Fairfield, New Jersey where we were so excited to have been a part of the production of some brand new ovarian cancer public service announcements. Eight … Continue reading
Ovarian Cancer National Alliance participated in health reform event
Today, President Obama held a health reform event for health care advocates after the signing of the historic health reform bill. The Ovarian Cancer National Alliance attended the event, at which Vice President Biden and President Obama spoke. The President … Continue reading
Posted in Blog Tagged Advocacy, Capitol Hill, Congress, insurance, President, White House Leave a comment
More study needed on vitamin D-ovarian cancer link
There isn’t enough evidence to back or debunk the claim that vitamin D can help reduce the risk of ovarian cancer, despite several recent studies making this claim, the authors of a new review of the scientific literature conclude. Health … Continue reading
UPDATES: Senate Dear Colleague letter for Ovarian Cancer Research Program
On this page, we will be providing updates of which Senators have signed onto the Dear Colleague letter requesting $30 million to be allocated to the Department of Defense’s Ovarian Cancer Research Program in FY 2011. NEW: View final letter … Continue reading
What does Health Reform Mean to Us?
The Ovarian Cancer National Alliance welcomes the improvements contained in the health insurance reform bill that was passed by Congress late Monday, March 22nd. For years, women with ovarian cancer have had to fight not only the disease, but to … Continue reading
Posted in News Tagged Action, Advocacy, Capitol Hill, clinical trials, Congress, insurance, President, White House Leave a comment
The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment (Gynecol Oncol)
OBJECTIVES: Ovarian cancer remains a major health problem for women. Although there is considerable clinico-pathological heterogeneity, the molecular genetic basis of ovarian cancer remains poorly understood. Recently, high-resolution genomic maps generated by genome-wide SNP analyses and novel sequencing technologies, have … Continue reading













